Multiple Myeloma - Survival Rate Statistics by Hospital
  • Home
  • Higher Risk Myeloma
  • Myeloma Blog
  • Myeloma Specialists Listing
  • Doctor Submissions
  • Contact Us

If you could Double your Multiple Myeloma survival rate and life expectancy, Wouldn't You?  Then why don't you???

6/21/2013

1 Comment

 
Picture
Parable of the Drowning Man
”There was a preacher who fell in the ocean and he couldn't swim. When a boat came by, the captain yelled, "Do you need help, sir?" The preacher calmly said "No, God will save me." A little later, another boat came by and a fisherman asked, "Hey, do you need help?" The preacher replied again, "No God will save me." Eventually the preacher drowned & went to heaven. The preacher asked God, "Why didn't you save me?" God replied, "But I sent you two boats!"


For those patients who have a myeloma specialist on their team and are part of an on-line or local support group, there is no need to read further unless you are just interested in understanding how smart you really are by being your own best advocate.
 
You may be saying what on earth is he thinking.  Of course, I would double my life expectancy if I could!!  Lets just look at the math.  There is about 80,000 myeloma patients in the USA and if the world has the same rate then there are a total of 1,750,000 people in the world living with multiple myeloma.  So it is my guess that the estimated 200 multiple myeloma specialists in the world are not able to see all of these patients.  Nor do I believe that there are enough support groups in total or support groups local to myeloma patients to satisfy this patient population.  So why do you need to be part of a support group and have a myeloma specialist on your medical team?

1) If you go to my web site www.myelomasurvival.com you will find that the average life expectancy for a myeloma patient is currently listed at 4 years by the US National Cancer Institute, whereas the patients of multiple myeloma specialists have excellent survival rates and have life expectancies of 8 to 10 years.    

2) In addition support group membership has the benefit of learning more about the newest and best treatments, getting feed back on side effects, caregiver fears and help, medical billing issues, friendship, fellowship, and support.  An audit that I conducted with some of the IMF support group leaders indicated that active support group members lived twice as long as the US National Cancer Institute published average.

There are two reasons why I think that people are not taking advantage of these two key elements for longer life expectancy.  The first is that the best multiple myeloma specialists have a life expectancy two times greater that the 4 years quoted by the National Cancer Institute, and if all people were obtaining this quality of care the National Cancer Institute life expectancy would be closer to 8 to 10 years.   In addition, you can get a second opinion for less than $300 from the web site 2ndMD at https://2nd.md/disease/multiplemyeloma, however it is my understanding that some of the multiple myeloma specialists listed have had few if any requests for a second opinion.  The second reason is that there are two on-line support groups, one by the LLS, Leukemia, Lymphoma, and Myeloma Society which meets every Tuesday and is based on a Chat Line format, and the Cure Panel Support Group  that is once a month, and uses an on-line interactive format.   I have participated  on both and there were only 2 to 3 people participating, and I was one of them.  How sad!   

Support Groups

If you are one of the hundreds of thousands of patients who do not have access to a support group you can be one of the initial  members of two great support groups.

- The Cure Panel On-Line Broadcast is hosted by Pat Killingsworth, who is a MM author, a tireless advocate, and founded an IMF support group in west Florida.  You can sign up for the next support group meeting which will be held on June 27th at 6:00PM if you just CLICK HERE.  The topic for the meeting - “Be Your Own Best Advocate: Becoming an Empowered Patient!”

- The LLS On-Line Myeloma Chat is held every Tuesday and you can register if you just CLICK HERE.

-  Another good resource is the Acor Myeloma Patient to Patient Support Group which is one that has been around for years and has close to 2000 members.  You can sign up to be on the list if you CLICK HERE.


Myeloma Specialists

- If you would like a second opinion from a myeloma specialist then you can find a good listing if you CLICK HERE.  An outline of how you can get a second opinion can be found if you CLICK HERE.

- If you do not have access to a myeloma specialist you can get an on-line second opinion from one of four excellent myeloma professionals at the web site.

https://2nd.md/disease/multiplemyeloma.

- And if you don't have access to one of the two possibilities above for a second opinion, you can ask your hematologist/oncologist to follow the mSmart program published by Mayo Clinic.  mSmart happens to be a cook book method of myeloma treatment that is intended to allow your hematologist/oncologist to follow the same methods used by Mayo Clinic and then to hopefully duplicate for you Mayo's excellent life expectancy and survival rates.  You can read my blog post on this subject if you CLICK HERE.

As always good luck and may God Bless your families myeloma journey/ Gary Petersen [email protected]

For more information on multiple myeloma go to the web site www.myelomasurvival.com or you can follow me on twitter at: https://twitter.com/grpetersen1


1 Comment

Multiple Myeloma meets Star Wars!  Will nanoparticles one day find, then kill myeloma cells, and provide the CURE?  Listen to the rebroadcast of this June 11th Cure Panel to find out more about  exciting new developments in nanotechnology for cancer.

6/3/2013

3 Comments

 
The Cure Panel Talk Show which featured Dr. Anil K. Patri who is Deputy Director at Nanotechnology Characterization Laboratory (NCL) at the National Cancer Institute. Dr. Patri  discussing "Nanotechnology in Oncology".  Now that the broadcast has aired you can listen to the a rebroadcast if you CLICK HERE.  In the first day it was rebroadcast 8655 times, a record for the Cure Panel program.

I have heard of nanotechnology, but was under the impression it was one of those way-out technologies with little if any practical application.  It, however, most likely made really great brain food for all the materials scientists of the world, who could now make workable machines that were really, really, really small.      And even when Priya Menon asked me to participate in a Cure Panel Broadcast on the subject, I hesitated, not really understanding how this could have any application for multiple myeloma.  So I dragged my feet in replying to her email until I at least had a chance to do a little research on the subject.  The very first thing that got my attention was that Doxil, a myeloma chemotherapy drug is a product of nanotechnology.   The old drug doxorubicin is coated with nanoparticles or as explained on the Doxil web site:
  • “STEALTH® technology is composed of lipid nanoparticles that incorporate a polyethylene glycol (PEG) coating. This coating helps evade the potential impact of the immune system and enables STEALTH® technology to provide the precise delivery of drugs to disease-specific areas of the body.”

Another drug for Breast Cancer called Abraxane is an Albumin-Bound Nanoparticle Drug.  This is not a new drug but a nano coating of a drug called Taxol, but is twice as effective in the new form than its uncoated sister drug.  The same mechanism that delivers more drug to the cancer cell will be used for many other cancer drugs including myeloma therapies.  There are also many other developments that Dr. Patri will be presenting.

You might wonder why you have not heard much about this initiative, and for one thing it just began in 2004.  As we are all painfully aware, all new drug development can take as much as 10 years or more to get from idea to FDA approval.   I found this quote," The National Cancer Institute (NCI) at the National Institutes of Health (NIH) recognized the value of nanotechnology in oncology applications. In 2004, NCI established the Alliance for Nanotechnology in Cancer (Alliance) by pledging approximately $150 million to the five year initiative to fund a constellation of eight Centers for Cancer Nanotechnology Excellence(Centers) and 12 Cancer Nanotechnology Platform Partnerships (Platforms), together with Multidisciplinary Research Training and Team Development awards (11 awardees) and the Nanotechnology Characterization Laboratory (NCL)."  



So now after close to 10 years in the making we are starting to see the fruits of their remarkable work.   A short bio of Dr. Patri follows:

Picture
Dr. Anil K. Patri is Deputy Director at Nanotechnology Characterization Laboratory (NCL) at the National Cancer Institute, Frederick. At NCL, team of scientists from multidisciplinary fields are working together to facilitate the development of nanomaterials intended for clinical use. Dr. Patri is involved in physico-chemical characterization and standardization of nanomaterials for the NCL and collaborates with scientists at National Institute of Standards and Technology (NIST) and Food and Drug Administration (FDA). Prior to joining NCL, he was working as Staff Scientist at Center for Biologic Nanotechnology at University of Michigan, where he developed dendrimers- based nanomaterials for targeting, imaging and drug delivery applications. Dr. Patri received his Ph.D. in Organic Chemistry from University of South Florida, M.Sc. in Organic Chemistry from Aligarh Muslim University, and B.Sc. in Organic Chemistry from Osmania University, India.

I look forward to hearing from you at the broadcast.  And as always may God Bless your Myeloma Journey.  Gary Petersen

For more information on multiple myeloma go to the web site www.myelomasurvival.com or you can follow me on twitter at: https://twitter.com/grpetersen1


3 Comments

    Author

    Gary R. Petersen
    [email protected]
    CLICK HERE for my myeloma journey

    ©2012 All Rights Reserved

    Categories

    All

    Archives

    January 2025
    August 2023
    March 2023
    October 2022
    February 2021
    October 2020
    September 2020
    August 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    August 2018
    June 2018
    May 2018
    April 2018
    January 2018
    November 2017
    October 2017
    September 2017
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012

    RSS Feed

Web Hosting by iPage